Generic Epclusa Price in India | $1595 3 months 84 Tablets | FREE Shipping to USA

If you have both hepatitis B and hepatitis C read this FDA WARNING here before starting treatment.

Note: Please complete your order, we will be shipping soon to our pre paid patients.

PLEASE READ THIS WEB PAGE CAREFULLY. 

 “No patient left behind” – Our promise.”

Generic Harvoni for $1495 | Free shipping to most countries

Generic Harvoni $895 – 12 weeks treatment, 84 tablets.

Generic Sovaldi  $695    – 12 weeks treatment, 84 tablets. 

Generic Daklinza $495 – 12 weeks treatment, 84 tablets. 

Generic Epclusa $1495 – 12 weeks treatment, 84 tablets.

Please call, 1-858-952-1077, our patient advocates 24/7  for more information.

100% Guaranteed Delivery.  100% Confidentiality.

How Do I Order? Click here.

generic harvoni price in india $1495 12 weeks 84 tablets, generic sovaldi price in india $695 12 weeks 84 tablets, generic epclusa price in india $2195 12 weeks 84 tablets, generic daklinza price in india $695 12 weeks 84 tablets

Click on the Chat Icon bubble on the bottom right.  Fill in your information and we’ll email you shortly.

This website is for patients and their loved ones looking for alternate sources of safe and quality medicine that they cannot afford in their home country.


Soul-of-Healing-Non-Profit

Thank you for your trust and voting our friend, Soul of Healing, Inc as 2016 Great Non Profits.  Please click on badge to read and leave us a review.

SunnyPharma.org is a friend of Soul of Healing Inc a US non profit 501(c)(3)  EIN 26-2232427 . Please verify our US non profit status here.

 

 


 

Generic Epclusa:

Epclusa price in India is $1495.  In the US its $75,000.  Epclusa is manufactured by Gilead Sciences. It is a combination of velpatasvir 100mg and sofosbuvir 400mg in one tablet to treat hepatitis C (HCV).  To buy Epclusa online price in India is a fraction of the cost.  It is the exact same molecular combination approved by the US Food and Drug Administration.  The FDA audits these facilities for product quality, safety and control in India, regularly.

Why India?

In the early 1960’s India has been mass producing generic pharmaceuticals for the world.  The pharmaceutical industry kicked in to 4th gear in the early 90’s.  India now supplies 70% of all generics to the American people.  India was the first country to manufacture large scale affordable HIV drugs for the African people and HIV populations around the world.  Again, India takes the lead in mass producing hepatitis C drugs for North America, Latin America, Europe, Africa and Asia.

 

generic harvoni price in india $1495 12 weeks 84 tablets, generic sovaldi price in india $695 12 weeks 84 tablets, generic epclusa price in india $2195 12 weeks 84 tablets, generic daklinza price in india $695 12 weeks 84 tabletsManufacturing Generic Epclusa:

Natco Pharma, Cipla, and Hetero Drugs are just some of the would be manufacturers of generic Epclusa . The license from Gilead Sciences allows Indian pharmaceutical companies to manufacture the identical molecular compound of Epclusa that is available in the US. Epclusa is made up of velpatasvir 100mg and sofosbuvir 400mg. Like generics of Harvoni, Sovaldi and Daklinza, Epclusa is a Direct Acting Antiviral (DAA).  DAAs have been revolutionary in treating hepatitis C with or without the need for peginterferon-alpha and ribavirin. 

Generic Epclusa Brand Names:

The most popular generic version of Epclusa is Sofosvel from Bangladesh, Velpanat and Velasof in India.  It won’t be too long until manufacturers like Cipla, Mylan, Dr. Reddys, Abbott and several others join in mass producing velpatasvir 100mg and sofosbuvir 400mg tablets.

generic harvoni price in UAE $1495 12 weeks 84 tablets, generic sovaldi price in UAE $695 12 weeks 84 tablets, generic epclusa price in UAE $2195 12 weeks 84 tablets, generic daklinza price in UAE $695 12 weeks 84 tablets

What is treated with Generic Epclusa?

Epclusa is essentially the be all universal or pan-genotype hepatitis C treatment.   Generic Epclusa is used to treat genotypes 1 to 6 chronic hepatitis C infection.  As its predecessors Harvoni and Sovaldi, its a single pill a day for 84 days for most HCV patients.

Who can be treated with generic Epclusa?

Generic Epclusa is the first hepatitis C treatment that is available to treat genotypes 2 and 3 without ribavirin for most patients.  Note: some patients require weight based ribavirin in combination with Epclusa.  Always consult with your doctor before starting Epclusa or any medical treatment or procedure.

FYI: cirrhosis can be caused by long term infection of hepatitis C.

“Advanced cirrhosis means decompensated liver that is extensively scarred and is not able to function properly.”

The average hepatitis C patient requires 12 weeks of treatment, 84 tablets of generic Epclusa for most prevalent genotypes in the US to be considered “cured”. However, some cases require 24 weeks, 168 tablets of generic Epclusa to “clear” the hepatitis C virus. Please read more about viral load here.

generic harvoni $1495 12 weeks 84 tablets, generic sovaldi $695 12 weeks 84 tablets, generic epclusa $2195 12 weeks 84 tablets, generic daklinza $695 12 weeks 84 tabletsTo recommend treatment, your doctor will have you do a test for the viral load of the virus.  The test will let your doctor know if its necessary to pursue treatment or not.  If the viral load is very low then most probably your physician will hold off on treatment, due to the $75,000 cost of Epclusa.  This is a very common practice for most doctors because it is known that insurance will not cover it unless your seriously ill and months away from death.  Your insurance company (technically) will only pay if you have a fibroscan of 3 and above.  Sometimes you can get lucky.

Unfortunately, our hepatitis C advocates have heard 100’s of heart wrenching stories from loved ones; if the treatment was given in time, their spouse, friend or family member would still be alive and well today.

 

buy generic harvoni online $1495 12 weeks 84 tablets, generic sovaldi online $695 12 weeks 84 tablets, generic epclusa online $2195 12 weeks 84 tablets, generic daklinza online $695 12 weeks 84 tabletsSummarize to get Epclusa:

1.  Hepatitis C test
2.  HCV Antibody test – to find out your genotype.
3.  HCV viral load – dangerous or not dangerous
4.  Doctor recommends treatment
5.  Request insurance to cover treatment costs
6.  If denied by insurance appeal several times
7.  Denied for treatment again, work with a patient assistance program
8.  Still refused treatment, give us a call at 1-858-952-1077
9.  Email Melissa McKnight at hcvmeds@gmail.com
10. Please verify all patient references in the email we send you

How do I start the treatment with Epclusa?

Once your doctor informs you have genotype 2 or 3 they will recommend Epclusa for treatment with or without ribavirin.  Although generic Eplcusa is pan-genotype (1 through 6) treatment for chronic HCV.

To order please fill out the chat bubble on the bottom right hand side or just call our San Diego, California number 1-858-952-1077. You can also email Melissa McKnight at hcvmeds@gmail.com.

Let your physician know that you will be working with an American non profit and and Indian non governmental organization to gain access to subsidized and licensed generic Epclusa from India.  All of our patients who have gone through our program informed their doctors about SoulofHealing.org and SunnyPharma.org.

FYI: 95% of American doctors refer us patients who have been denied by insurance or cannot afford their copay.

Who are the likely candidates for treatment with Epclusa?generic harvoni price in india $1495 12 weeks 84 tablets, generic sovaldi price in india $695 12 weeks 84 tablets, generic epclusa price in india $2195 12 weeks 84 tablets, generic daklinza price in india $695 12 weeks 84 tablets

Many baby boomers, born between 1943 to 1965, have a high incidence of HCV infection.  Pan-genotype hepatitis C treatment for all genotype 1 to 6.  Prior to Epclusa there was no treatment option for genotypes 2 & 3 without ribavirin.

How did the Baby Boomers get afflicted with hepatitis C?

In early to mid 1900’s in the US, hygiene and blood borne infections were not well understood.  Doctors’ often performed surgeries with unwashed hands.  During the South Korean war many doctors would operate on multiple patients without gloves and hand washing.  Essentially moving infection from one patient to another unknowingly.  Contamination by blood was common and sterilization practices of medical instruments were sub par.

Hepatitis C made leaps and bounds in America during this dark age of medical and clinical science.  We now have a fighting chance with Direct Acting Antivirals like Sovaldi, Harvoni, Epclusa and Daklinza.  Its an amazing opportunity to treat an infectious disease with one pill a day for 84 days. Talk to your doctor before starting Epclusa or any medical treatment or procedure.

FYI: 75% of all baby boomers do not know they’re infected with hepatitis C

Prior to 1989, tests for hepatitis C did not exist, you were positive if you were non A & B positive.  Non A & B meant nor hepatitis A or hepatitis B, it was hepatitis but nomenclature was not designated for the infection at that time.

“Majority of the infections are NOT due to drug use, but through contaminated blood and poorly sterilized medical equipment according to new research published by Journal of American Medical Association.”

Once hepatitis C was clinically understood, screening, testing and preventative measures were put in place.  Due to the nature of the virus being highly infectious with high mortality rates, hepatitis C was finally getting the needed serious attention it deserved.

generic harvoni price in india $1495 12 weeks 84 tablets, generic sovaldi price in india $695 12 weeks 84 tablets, generic epclusa price in india $2195 12 weeks 84 tablets, generic daklinza price in india $695 12 weeks 84 tabletsAfter the Treatment with a licensed generic Epclusa?

You’ve completed your treatment, now what.  Your doctor should have asked you to take a viral load test after 8 weeks in to your treatment.  Compare the viral load with your baseline before you started the treatment.  Usually, the generic Epclusa is working and fighting the hepatitis C virus.  So, your viral load should be lower than it was earlier.  After you completed the treatment, take another viral load test 3 months down the road.  Your test results should show that no virus detected.  Congratulations, you have completed your treatment and hepatitis C virus load is not detectable.  You’ve won, you beat the hepatitis C virus.

FYI: SVR12 means sustained viral response after 12 weeks after completing treatment. SVR24 means sustained viral response after 24 weeks after completing treatment.

Hundred’s of patients have sent us lab tests stating that they have cleared the virus. We always ask our patients to take another viral load test after 12 to 18 months of treatment. This will give further evidence that you no longer have hepatitis C and can live a normal healthy life.

We understand that after receiving your treatment from Sunny Pharma you want to forget about this chapter in your life. However, we strongly urge you to communicate with our hepatitis C advocates by email (hcvmeds@gmail.com) or a simple phone call (1-858-952-1077) to let us know that you have cleared the virus.

We want to hear from ALL of our patients’ and their loved ones that the generic Epclusa indeed work to cure hepatitis C.

All generic versions of Harvoni , Sovaldi and Epclusa are manufactured under the license and supervision of Gilead Sciences and the FDA.

Medical disclaimer:  Over the past year an inconclusive new study states Direct Acting Antivirals like Sovaldi, Harvoni, Epclusa, Daklinza and others can be fatal.  Please do not rely on  SoulofHealing.org and SunnyPharma.org as an alternative to medical advice from your doctor or other professional healthcare provider. Please consult with your physician for any and all medical treatment and medical care.


Generic Epclusa, Generic Harvoni, Generic Sovaldi and Generic Daklinza Shipping to Most countries

As of 2015, India provides over 80% of generic drugs to the American people.   The New York Times reports that India will be the #1 destination for many Americans and Europeans seeking high quality healthcare for those with limited insurance coverage.  The article also states that Online Indian Pharmacies will replace most online Canadian pharmacies.  The primary reason is Americans/Europeans will not be able to afford their prescription medicine even from Canada.

India will be one of the few safe alternatives due to its strict government regulations and low prices for quality prescription medicine.  How?  Indian pharmaceutical companies have a population base of 1.2 billion consumers and patients.

Prescription medicine from India, overall, is of high quality, easy to find, purchase and have delivered to your front door.

Our partner are Manipal Hospital (Mayo Clinic), Wockhardt Hospitals in association with Harvard Medical International.

Sunny Pharma Partner Clinics and Hospitals

If you’re planning to come to India for medicine and medical care, we provide Full Concierge Service from most Indian International Airports to your hotel or residence apartment.  We will be available 24/7 when you’re in India.

Please let us know all necessary details in advance so we can efficiently cater to your needs.

If you want to schedule a time to talk to  a doctor, pharmacist or advocate, we’re here 24 hours a day, 1-858-952-1077 and by email at hcvmeds@gmail.com


   A Personal Letter to Our Community

Dear HCV Patients & Loved Ones:

 We want to do our best to reach the affected hepatitis C/HCV population in the most efficient manner.  (We require more volunteers, patient outreach coordinators/specialists.)

We understand, that many patients’ and their families and friends have had a difficult time getting approval for Sovaldi, Harvoni, Epclusa or Daklinza through their insurance companies.  Essentially, insurance companies tell us we don’t have a fighting chance unless our fibroscan is 3 or greater.

Who wants to wait until their liver is more compromised and diseased to see if they’re eligible for treatment.

Talk to your doctor first and then make the commitment to get treated with a licensed generic that is approved by the US Food and Drug Administration. 

We strongly believe that all individuals have a right to life and access to medical care and medicine wherever they reside.

In today’s world, there is no reason that anyone that is relatively mobile can have access to affordable treatment and medical care anywhere in the world.

We as a community should not be limited to access due to our residence in a country where hepatitis C/HCV treatment is $95,000 to $190,000.  There are options and those options should be carefully weighed and exercised.  Its a matter of life and death and should not and will not be based on financial means.

Contemplating the costs and affordability of specialty medicines causes much grief and undue stress on the physiology and psychology of the patient as well as their loved ones.  The stress effects everyone in the close knit network of the patient.  Do not make compromises on your health when affordable treatment can be delivered to your front door.

Our country’s legislators, insurance lobbyists and pharmaceutical lobbyists work tirelessly to make life saving hepatitis C treatments like Epclusa, Sovaldi, Daklinza and Harvoni are out of reach for 90% of the population.  Is that fair?  Is that just? 

The nouveau response to accessing Sovaldi, Harvoni, Epclusa or Daklinza is to get a mortgage like loan to pay for the medication.  This idea was concocted from some of the most prestigious universities’ professors in the US.  They’re adding insult to injury and pretty much plain disregard to our hepatitis C communities.

Please do not wait for our law makers and the lobbyists to develop a moral compass that will benefit you in obtaining life saving generic hepatitis C treatments.  We hope and pray that it will happen, but we’re not holding our breath. 

Lucia P
-HCV Activist

Hepatitis C activist wants to have access to affordable treatment.